| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6801916 | Journal of Substance Abuse Treatment | 2018 | 4 Pages |
Abstract
Receiving XR-NTX prior to jail release for opioid use disorder appears to increase the treatment retention rate as compared to commencing after release. The treatment attrition and striking rate of overdose deaths are concerning, and support expanded availability of opioid agonist treatments prior to release and other evidence-based supports and retention strategies in the community.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Thomas Lincoln, Benjamin D. Johnson, Patrick McCarthy, Ellen Alexander,